Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Basal Cell 14Neoplasms 5Skin Neoplasms 4Pancreatic Neoplasms 4Basal Cell Nevus Syndrome 4Prostatic Neoplasms 3Breast Neoplasms 3Neoplasm Metastasis 2Medulloblastoma 2Leukemia, Myeloid, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hematologic Neoplasms 2Carcinoma 2Adenocarcinoma 2Thrombocytosis 1Stomach Neoplasms 1Sarcoma 1Recurrence 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Platinum-Resistant Fallopian Tube Carcinoma 1Pancreatic Diseases 1Ovarian Neoplasms 1Odontogenic Cysts 1Neuroectodermal Tumors, Primitive 1Neoplasms, Basal Cell 1Neoplasms by Site 1Neoplasms by Histologic Type 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1

Interventions

Magnetic Resonance Spectroscopy 12gallium Ga 68 dotatate 6Everolimus 6lutetium Lu 177 dotatate 5Radiosurgery 5Proton Therapy 5Bevacizumab 5pembrolizumab 4Surveys and Questionnaires 4Specimen Handling 4Hydroxyurea 4abemaciclib 3Tranexamic Acid 3Surgical Procedures, Operative 3Sodium Chloride 3Ga(III)-DOTATOC 32-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3vistusertib 2trametinib 2ribociclib 2arginyllysine 2aldesleukin 2Yoga 2Whole Body Imaging 2Sunitinib 2Saline Solution 2Ropivacaine 2Radiotherapy 2Protons 2Observation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Meningioma × HhAntag691 × Clear all
NCT02523014 2026-06-02

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Alliance for Clinical Trials in Oncology

Phase 2 Recruiting
124 enrolled
CNS

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡